John Brendan Doyle - 15 Feb 2024 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role: Chief Financial Officer
Signature: /s/ Lisa Ricciardi, Attorney-in-Fact
Issuer symbol: CGTX
Transactions as of: 15 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 20 Feb 2024, 16:13:35 UTC
Previous filing: 03 May 2023
Next filing: 03 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGTX	Common Stock	Award	$0	+20,000	+18%	$0.000000	129,824	15 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CGTX	Stock Option (Right to Buy)	Award	$0	+20,000		$0.000000	20,000	15 Feb 2024	Common Stock	20,000	$1.98	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2	The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.